Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-007-0472-1
Full Text
Open PDFAbstract
Available in full text
Date
April 12, 2007
Authors
Publisher
Springer Science and Business Media LLC